Drug Facts
Composition & Profile
Identifiers & Packaging
PRINCIPAL DISPLAY PANEL - SHIPPER LABEL Eisai Manufacturing Limited Allegato DQA-035/XXXX New Chemical Entity Demand Chain Unit European Knowledge Centre Mosquito Way-Hatfield, Herts, AL 109SN United Kingdom HALAVEN® (eribulin mesylate) Injection, for intravenous use- 0.5mg/ml, 2 ml Store at 15° - 25°C (59° - 77°F). DO NOT FREEZE QTY: 00XXX EXP: MM-YYYY LOT: F1XXYZZZ (22) 900XXX MMYYYY F1XXYZZZ 7 NDC 43624-002-01 ( 0X) 50X XXXXX 00X X X0 XXX Manufactured by : BSP Pharmaceuticals SpA-Latina Scalo, Italy. Image (eribulin mesylate) Injection1 mg/2 mL(0.5 mg/mL)For Intravenous Use
- PRINCIPAL DISPLAY PANEL - SHIPPER LABEL Eisai Manufacturing Limited Allegato DQA-035/XXXX New Chemical Entity Demand Chain Unit European Knowledge Centre Mosquito Way-Hatfield, Herts, AL 109SN United Kingdom HALAVEN® (eribulin mesylate) Injection, for intravenous use- 0.5mg/ml, 2 ml Store at 15° - 25°C (59° - 77°F). DO NOT FREEZE QTY: 00XXX EXP: MM-YYYY LOT: F1XXYZZZ (22) 900XXX MMYYYY F1XXYZZZ 7 NDC 43624-002-01 ( 0X) 50X XXXXX 00X X X0 XXX Manufactured by : BSP Pharmaceuticals SpA-Latina Scalo, Italy. Image (eribulin mesylate) Injection1 mg/2 mL(0.5 mg/mL)For Intravenous Use
Overview
No description available yet.
Dosage & Administration
Not available
Warnings & Precautions
No warnings available yet.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.